{
    "nctId": "NCT02121873",
    "briefTitle": "The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage",
    "officialTitle": "The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Preneoplastic Conditions, Ductal Carcinoma in Situ",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 6,
    "primaryOutcomeMeasure": "Identify early epithelial somatic mutations/indels in precancerous breast ducts by comparing genetic DNA sequences from cells obtained from venous blood and ductal lavage",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Be female\n* Have at least one intact nipple\n* If over 50, have had a normal mammogram within 12 months prior to the enrollment date\n* Have a normal physical examination of the breast to be studied within 12 months prior to the enrollment date\n* Be \\> 18 years of age\n* Sign the informed consent form\n\nExclusion Criteria:\n\n* Be currently pregnant or pregnant within the last 12 months\n* Be currently lactating or lactated within the last 12 months\n* Have received chemotherapy in the last 12 months\n* Have had an abnormal mammogram within the last year\n* Have had any subareolar or other surgery (papilloma resections, biopsies or fine needle aspirations) within 2 centimeters of the nipple (biopsies and fine needle aspirations \\>2 centimeters from the nipple are acceptable)\n* Have active infections or inflammation in a breast to be studied\n* Have a known allergy to lidocaine\n* Be unwilling to sign informed consent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}